– Guidelines include TAILORx-defined cutoff of 26 for determining chemotherapy benefit in node-negative disease, and recommend that more women with limited nodal involvement may avoid chemotherapy- Oncotype DX® test recommended based on prospective lan… […]
Comprehend reveals new solution at DIA 2019, designed for clinical trial process improvement and greater ICH E6(R2) compliance.
REDWOOD CITY, Calif., June 18, 2019 /PRNewswire/ — Most sponsor companies have relied on outsourcing to support their por… […]
SpineTRACK represents the only industry-sponsored spine registry that qualified providers to receive positive payment adjustments up to seven percent on all Medicare reimbursements in 2020
SAN DIEGO, May 30, 2019 /PRNewswire/ — NuVasive, Inc. (NASDA… […]
SAN DIEGO, May 21, 2019 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet p… […]
Early data on pancreatic cancer detection presented at Digestive Disease Week® 2019
SAN DIEGO, May 20, 2019 /PRNewswire/ — Early research using blood-based methylated DNA markers, identified through the longstanding collaboration between Exact Scien… […]
Confirm BioSciences Wins Prestigious Award Second Year in a Row; Recognized for Standout Employee Engagement
SAN DIEGO, May 16, 2019 /PRNewswire/ — Confirm BioSciences, the leading developer of high-quality diagnostic testing and health and wellness… […]
– Results Confirm the Posterior Trajectory as an Additional Surgical Delivery Route for VY-AADC in Patients with Parkinson’s Disease- Treatment with VY-AADC Improved Good ON Time (ON Time Without Troublesome Dyskinesia) by 1.7 Hours and Reduced OFF Tim… […]
– More than 60% of Patients Treated with Once-Daily Opicapone 50 mg Experienced an Increase in Total ON Time of One Hour or Longer- Data Analysis from the BIPARK-1 and BIPARK-2 Phase III Studies Highlighted as an Oral Presentation at the 2019 American … […]
SAN DIEGO, April 23, 2019 /PRNewswire/ — The use of Minimally Invasive Parafascicular Surgery (MIPS) techniques for removal of traumatic hematoma is encouraging, innovative and promising. Those are the insights from Julian Bailes, MD, Chair of the … […]
Patients Receiving 5 mg Daily Doses of VK2809 Demonstrated Statistically Significant Median Reduction in Liver Fat Content of 53.8%88% of Patients Receiving VK2809 Experienced >= 30% Reduction in Liver Fat Content at 12 Weeks, Including all Patients Re… […]
Copyright © 2019 San Diego Biotechnology Network (DBA of Comprendia. LLC)
